These interventions aim to restore intestinal microecological balance, increasingly recognized as pivotal in the pathophysiology of these conditions
Weight Loss: Like GLP-1 drugs, it also acts on brain pathways that control hunger and satiety, leading to significant weight reduction in many patients
Important safety considerations include risks of pancreatitis (severe persistent abdominal pain), gallbladder disease (right upper abdominal pain, jaundice), diabetic retinopathy complications (sudden vision changes), and dehydration/acute kidney injury
the third received liraglutide, a GLP-1 RA, with usual physical activity
Full therapeutic benefit typically emerges within 48 weeks as your body's GLP-1 pathways become optimally activated
Some can cope with daily injections with support